Hypothalamic-pituitary-adrenal (HPA) axis functioning as predictor of antidepressant response–Meta-analysis

Neuroscience and Biobehavioral Reviews

Volumn 83, Issue , 2017, Pages 200-211

  Fischer, Susanne ^a,b   Macare, Christine ^a   Cleare, Anthony J ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antidepressant; Cortisol; Depression; Hypothalamic pituitary adrenal axis; Treatment response

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CORTICOTROPIN; DESIPRAMINE; DOSULEPIN; DOXEPIN; ESCITALOPRAM; FLUOXETINE; HYDROCORTISONE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; NEFAZODONE; NOMIFENSINE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SERTRALINE; TOLOXATONE; TRANYLCYPROMINE; TRYPTOPHAN; UNINDEXED DRUG; VENLAFAXINE; ZIMELDINE;

COMORBIDITY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DRUG RECEPTOR BINDING; EFFECT SIZE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; STANDARDIZATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; META ANALYSIS;

ANIMALS; ANTIDEPRESSIVE AGENTS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM;

EID: 85031812506     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2017.10.012     Document Type: Review

References (36)

1. Binder, E.B., Künzel, H.E., Nickel, T., Kern, N., Pfennig, A., Majer, M., Uhr, M., Ising, M., Holsboer, F., HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 34 (2009), 99–109.
2. Borenstein, M., Hedges, L.V., Higgins, J.P.T., Rothstein, H.R., Introduction to Meta-Analysis. 2009, Wiley.
3. Bradley, A.J., Dinan, T.G., A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J. Psychopharmacol. 24 (2010), 91–118.
4. Carroll, B.J., Use of the dexamethasone suppression test in depression. J. Clin. Psychiatry 43 (1982), 44–50.
5. Chrousos, G.P., Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5 (2009), 374–381.
6. Cleare, A., Pariante, C.M., Young, A.H., Anderson, I.M., Christmas, D., Cowen, P.J., Dickens, C., Ferrier, I.N., Geddes, J., Gilbody, S., Haddad, P.M., Katona, C., Lewis, G., Malizia, A., McAllister-Williams, R.H., Ramchandani, P., Scott, J., Taylor, D., Uher, R., Members of the Consensus, M, Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J. Psychopharmacol. 29 (2015), 459–525.
7. Clow, A., Hucklebridge, F., Stalder, T., Evans, P., Thorn, L., The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 35 (2010), 97–103.
8. Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000), 455–463.
9. Fischer, S., Cleare, A.J., Cortisol as a predictor of psychological therapy response in anxiety disorders-Systematic review and meta-analysis. J. Anx. Disord. 47 (2017), 60–68.
10. Fischer, S., Duncko, R., Hatch, S.L., Papadopoulos, A., Goodwin, L., Frissa, S., Hotopf, M., Cleare, A.J., Sociodemographic, lifestyle, and psychosocial determinants of hair cortisol in a South London community sample. Psychoneuroendocrinology 76 (2017), 144–153.
11. Fischer, S., Strawbridge, R., Vives, A.H., Cleare, A.J., Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis. Br. J. Psychiatry 210 (2017), 105–109.
12. Heim, C., Newport, D.J., Mletzko, T., Miller, A.H., Nemeroff, C.B., The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33 (2008), 693–710.
13. Herane Vives, A., De Angel, V., Papadopoulos, A., Strawbridge, R., Wise, T., Young, A.H., Arnone, D., Cleare, A.J., The relationship between cortisol, stress and psychiatric illness: new insights using hair analysis. J. Psychiatr. Res. 70 (2015), 38–49.
14. Holsboer, F., von Bardeleben, U., Wiedemann, K., Muller, O.A., Stalla, G.K., Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol. Psychiatry 22 (1987), 228–234.
15. Horstmann, S., Binder, E.B., Glucocorticoids as predictors of treatment response in depression. Harv. Rev. Psychiatry 19 (2011), 125–143.
16. Izawa, S., Miki, K., Tsuchiya, M., Mitani, T., Midorikawa, T., Fuchu, T., Komatsu, T., Togo, F., Cortisol level measurements in fingernails as a retrospective index of hormone production. Psychoneuroendocrinology 54 (2015), 24–30.
17. Joels, M., Baram, T.Z., The neuro-symphony of stress. Nat. Rev. Neurosci. 10 (2009), 459–466.
18. Juruena, M.F., Pariante, C.M., Papadopoulos, A.S., Poon, L., Lightman, S., Cleare, A.J., Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. Br. J. Psychiatry 194 (2009), 342–349.
19. Juruena, M.F., Pariante, C.M., Papadopoulos, A.S., Poon, L., Lightman, S., Cleare, A.J., The role of mineralocorticoid receptor function in treatment-resistant depression. J. Psychopharmacol. 27 (2013), 1169–1179.
20. Lipsey, M.W., Wilson, D.B., Practical Meta-Analysis. 2001, SAGE Publications, Thousand Oaks, USA.
21. Markopoulou, K., Fischer, S., Papadopoulos, A., Poon, L., Rane, L., Fekadu, A., Cleare, A.J., under revision. Comparing hypothalamo-pituitary-adrenal function in treatment resistant unipolar and bipolar depression.
22. Miller, R., Stalder, T., Jarczok, M., Almeida, D.M., Badrick, E., Bartels, M., Boomsma, D.I., Coe, C.L., Dekker, M.C., Donzella, B., Fischer, J.E., Gunnar, M.R., Kumari, M., Lederbogen, F., Power, C., Ryff, C.D., Subramanian, S.V., Tiemeier, H., Watamura, S.E., Kirschbaum, C., The CIRCORT database: reference ranges and seasonal changes in diurnal salivary cortisol derived from a meta-dataset comprised of 15 field studies. Psychoneuroendocrinology 73 (2016), 16–23.
23. Nicolaides, N.C., Kyratzi, E., Lamprokostopoulou, A., Chrousos, G.P., Charmandari, E., Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation 22 (2015), 6–19.
24. Ribeiro, S.C., Tandon, R., Grunhaus, L., Greden, J.F., The DST as a predictor of outcome in depression: a meta-analysis. Am. J. Psychiatry 150 (1993), 1618–1629.
25. Rohleder, N., Wolf, J.M., Wolf, O.T., Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 35 (2010), 104–114.
26. Skoluda, N., Strahler, J., Schlotz, W., Niederberger, L., Marques, S., Fischer, S., Thoma, M.V., Spoerri, C., Ehlert, U., Nater, U.M., Intra-individual psychological and physiological responses to acute laboratory stressors of different intensity. Psychoneuroendocrinology 51 (2015), 227–236.
27. Skoluda, N., Linnemann, A., Nater, U.M., The role of week(end)-day and awakening time on cortisol and alpha-amylase awakening responses. Stress 19 (2016), 333–338.
28. Stalder, T., Kirschbaum, C., Analysis of cortisol in hair–state of the art and future directions. Brain Behav. Immun. 26 (2012), 1019–1029.
29. Stetler, C., Miller, G.E., Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73 (2011), 114–126.
30. Valentino, R.J., Commons, K.G., Peptides that fine-tune the serotonin system. Neuropeptides 39 (2005), 1–8.
31. Valentino, R.J., Van Bockstaele, E., Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur. J. Pharmacol. 583 (2008), 194–203.
32. Van Cauter, E., Leproult, R., Kupfer, D.J., Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81 (1996), 2468–2473.
33. Waters, R.P., Rivalan, M., Bangasser, D.A., Deussing, J.M., Ising, M., Wood, S.K., Holsboer, F., Summers, C.H., Evidence for the role of corticotropin-releasing factor in major depressive disorder. Neurosci. Biobehav. Rev. 58 (2015), 63–78.
34. Weckesser, L.J., Plessow, F., Pilhatsch, M., Muehlhan, M., Kirschbaum, C., Miller, R., Do venepuncture procedures induce cortisol responses? A review, study, and synthesis for stress research. Psychoneuroendocrinology 46 (2014), 88–99.
35. de Kloet, E.R., Joels, M., Holsboer, F., Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6 (2005), 463–475.
36. de Kloet, E.R., Derijk, R.H., Meijer, O.C., Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007), 168–179.